Literature DB >> 7648469

A system for assessment of monokine gene expression using human whole blood.

D A Joyce1, J H Steer, M W Beilharz, R Stranger.   

Abstract

Monocyte derived cytokines (monokines) are important mediators in inflammatory diseases and cancer. Control of monokine expression is also a major therapeutic target in autoimmune inflammation. Whole blood cultures permit examination of monokine expression under conditions which emulate the in-vivo environment whilst avoiding many of the artefacts associated with monocyte separation and culture. Here we describe a system for measuring interleukin-1 beta, interleukin-1 alpha, interleukin-6 and tumour necrosis factor-alpha mRNA in stimulated human whole blood ex-vivo, which can be applied to specimens from treated patients. Oligodeoxyribonucleotide probes are designed to allow standardisation of hybridisation and washing procedures. Washing and reprobing of membranes in appropriate sequence permits measurement of each monokine mRNA and mRNA for glyceraldehyde-3-phosphate dehydrogenase in only 7 ml of lipopolysaccharide-stimulated human blood. The method has been used successfully in studies of dexamethasone and methotrexate action on lipopolysaccharide stimulated IL-beta gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648469     DOI: 10.1016/1050-3862(95)00104-2

Source DB:  PubMed          Journal:  Genet Anal


  2 in total

1.  Limited dynamic range of immune response gene expression observed in healthy blood donors using RT-PCR.

Authors:  Kevin McLoughlin; Ken Turteltaub; Danute Bankaitis-Davis; Richard Gerren; Lisa Siconolfi; Kathleen Storm; John Cheronis; David Trollinger; Dennis Macejak; Victor Tryon; Michael Bevilacqua
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

2.  Altered leucocyte trafficking and suppressed tumour necrosis factor alpha release from peripheral blood monocytes after intra-articular glucocorticoid treatment.

Authors:  J H Steer; D T Ma; L Dusci; G Garas; K E Pedersen; D A Joyce
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.